Vor Bio
The Director, Regulatory Strategy leads global regulatory efforts for immunology development programs, shaping strategies for product development, approval, and lifecycle management while ensuring compliance with global regulatory requirements. The role involves strategic leadership, regulatory agency engagement, submission oversight, cross-functional collaboration, and people leadership.
Vor Bio is a clinical-stage cell and genome engineering company developing novel hematopoietic stem cell-based therapies for cancer. The company is focused on transforming the treatment of hematological malignancies through engineered stem cell transplantation and targeted therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Vor Bio.
Right around the average for this role
Vor, with new CEO, changes course to target autoimmune disease
Jun 26, 2025
Executive Regulatory Science Director, Respiratory & Immunology
AstraZeneca
Executive Regulatory Science Director, Respiratory & Immunology
AstraZeneca
Senior Director (Sr. Principal Scientist), Regulatory Affairs Liaison
MSD
Director (Principal Scientist), Global Regulatory Liaison
MSD
Executive Regulatory Science & Strategy Director, Oncology
AstraZeneca
Regulatory Affairs Manager
Otsuka America